Cellosaurus logo
expasy logo

Cellosaurus RMA-S (CVCL_2180)

[Text version]
Cell line name RMA-S
Synonyms RMA/S; RMAS
Accession CVCL_2180
Resource Identification Initiative To cite this cell line use: RMA-S (RRID:CVCL_2180)
Comments Characteristics: Deficient in antigen processing.
Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
Cell type: T-cell; CL=CL_0000084.
Disease Mouse leukemia (NCIt: C21604)
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: C57BL/6.
Hierarchy Parent: CVCL_J385 (RMA)
Children:
CVCL_WK58 (RMA-S-A*2402)CVCL_C0DD (RMA-S.Trh4)CVCL_YB11 (RMA-SKb+)
CVCL_YB12 (RMA-SKb-)
Category Cancer cell line
Publications

PubMed=2066183; DOI=10.1002/ijc.2910470711
Ljunggren H.-G., Ohlen C., Hoglund P., Franksson L., Karre K.
The RMA-S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejection.
Int. J. Cancer Suppl. 6:38-44(1991)

PubMed=11132152; DOI=10.1007/s002510000254
Howell D., Levitt J.M., Foster P.A., Guenther M.M., Shawar S.M., Rich R.R., Rodgers J.R.
Heterogeneity of RMA-S cell line: derivatives of RMA-S cells lacking H2-Kb and H2-Db expression.
Immunogenetics 52:150-154(2000)

PubMed=17982631; DOI=10.3892/or.18.6.1463
Komohara Y., Harada M., Ishihara Y., Suekane S., Noguchi M., Yamada A., Matsuoka K., Itoh K.
HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma.
Oncol. Rep. 18:1463-1468(2007)

Cross-references
Cell line databases/resources Lonza; 60
TOKU-E; 4090
Anatomy/cell type resources BTO; BTO_0006563
Chemistry resources ChEMBL-Cells; CHEMBL3307428
ChEMBL-Targets; CHEMBL614880
PubChem_Cell_line; CVCL_2180
Encyclopedic resources Wikidata; Q54950645
Entry history
Entry creation04-Apr-2012
Last entry update19-Dec-2024
Version number17